Tayanan Srisupa - OlanSasitorn SirithoKulvara KittisaresJiraporn JitprapaikulsanChanjira SathukitchaiNaraporn PrayoonwiwatBangkok Hospital Medical CenterBumrungrad International HospitalFaculty of Medicine, Siriraj Hospital, Mahidol University2019-08-282019-08-282018-02-01Multiple Sclerosis and Related Disorders. Vol.20, (2018), 115-12122110356221103482-s2.0-85041631163https://repository.li.mahidol.ac.th/handle/123456789/46976© 2018 Elsevier B.V. Background: Plasma exchange (PLEX) is routinely performed in neuromyelitis optica spectrum disorders (NMOSD) patients with an acute attack who do not respond to corticosteroids treatment. Objective: To compare treatment outcomes in NMOSD patients with an acute attack between the two groups. Methods: We retrospectively studied 67 attacks from 52 NMOSD patients. Outcome measurements using Expanded Disability Status Scale (EDSS), modified Rankin Scale (mRS) were compared. Results: There were 23 IVMP responders, 16 IVMP non-responders refusing PLEX, 12 IVMP non-responders/PLEX responders, and 16 IVMP/PLEX non-responders. The IVMP-responders showed faster improvement since the time of discharge but seemed to have less treatment benefit over time. However, IVMP non-responders/PLEX responders showed continuous and maximum improvement at 6 months (ΔEDSS from nadir: 1 for IVMP-responders vs 0.5 for IVMP non-responders without PLEX vs 2.75 IVMP non-responders/PLEX-responders vs 0.5 IVMP/PLEX non-responders; p = 0.49) and had comparable outcomes to the IVMP-responders (nadir EDSS 8.0 to 5.25 [ΔEDSS = 2.75] vs nadir EDSS 6.5 to 5.0; [ΔEDSS = 1.5], respectively). Conclusion: Add - on PLEX treatment in NMOSD patients with an acute attack should be considered in those not responding to IVMP alone.Mahidol UniversityMedicineNeuroscienceArticleSCOPUS10.1016/j.msard.2018.01.010